On July 24, the doctors at UConn John Dempsey Hospital administered a gene therapy candidate in a clinical trial for Glycogen Storage Disease (GSD) Type Ia. This video from the University of Connecticut features interviews with the first patient and David Weinstein, M.D., GSD program director. The one-time therapy will be evaluated for effectiveness six weeks after infusion. 


Previous articleCRISPR-Cas12a More Precise Than CRISPR-Cas9
Next articleNovel Method Allows Researchers to Precisely Engineer and Monitor Protein Function